Healthcare Innovation October 18, 2024
Mark Hagland

The recent stumbles of the national pharmacy chains offer important insights

As Contributing Editor Geert De Lombaerde reported on Oct. 18, the Woonsocket, Rhode Island-based CVS Health announced that it was replacing its CEO. De Lombaerde’s report began thus: “CVS Corp. president and Chief Executive Officer Karen Lynch stepped down from her job Oct. 17 to be replaced by the leader of the company’s Caremark pharmacy benefit manager. In announcing the change at the helm—which comes just a few months after Lynch shuffled some senior leadership roles and took charge of CVS’ Aetna insurance group—Rhode Island-based CVS also said its third-quarter results will come in well below expectations because of higher-than-expected benefit costs, a trend that first surfaced in the...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Pharma, Pharma / Biotech
CVS, Walgreens & Walmart's healthcare strategy faces headwinds: 10 notes from 2024
FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions
The CMS NHE 2023 Report: An Incomplete Picture at a Pivotal Time
Mark Cuban's 2025 plans
Pharma At A Crossroads: Navigating Cost Pressures And Regulatory Shifts In 2025

Share This Article